CORBUS PHARMACEUTICALS

corbus-pharmaceuticals-logo

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases by leveraging its pipeline of endocannabinoid system-targeting synthetic drug candidates. The Company's lead product candidate, lenabasum, is a novel, synthetic, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to resolve chronic inflammation and fibrotic processes. Lenabasum i... s currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Corbus is also developing a pipeline of drug candidates from more than 600 novel compounds targeting the endocannabinoid system. The pipeline includes CRB-4001, a 2nd generation, peripherally-restricted, selective cannabinoid receptor type 1 (CB1) inverse agonist. Potential indications for CRB-4001 include NASH, among others. Corbus plans to start a Phase 1 study of CRB-4001 in 2019, intended to be followed by a National Institutes of Health (NIH)-funded proof-of-concept Phase 2 study.

#SimilarOrganizations #People #Financial #Event #Website #More

CORBUS PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Clinical Trials Pharmaceutical

Founded:
2009-01-01

Address:
Norwood, Massachusetts, United States

Country:
United States

Website Url:
http://www.corbuspharma.com

Total Employee:
51+

Status:
Active

Contact:
(617) 963-0100

Email Addresses:
[email protected]

Total Funding:
196.95 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.

Current Employees Featured

rachael-brake_image

Rachael Brake
Rachael Brake Chief Scientific Officer @ Corbus Pharmaceuticals
Chief Scientific Officer
2021-12-01

robert-discordia_image

Robert Discordia
Robert Discordia COO @ Corbus Pharmaceuticals
COO
2019-08-01

yuval-cohen_image

Yuval Cohen
Yuval Cohen Chief Executive Officer @ Corbus Pharmaceuticals
Chief Executive Officer
2013-07-01

barbara-white_image

Barbara White
Barbara White Chief Medical Officer & Head of Researchv @ Corbus Pharmaceuticals
Chief Medical Officer & Head of Researchv

ed-karski_image

Ed Karski
Ed Karski Global Head, Procurement @ Corbus Pharmaceuticals
Global Head, Procurement
2019-02-01

sean-moran_image

Sean Moran
Sean Moran CFO @ Corbus Pharmaceuticals
CFO
2014-01-01

craig-millian_image

Craig Millian
Craig Millian Chief Operating Officer @ Corbus Pharmaceuticals
Chief Operating Officer
2021-09-01

Founder


bruce-montgomery_image

Bruce Montgomery

jonathan-mow_image

Jonathan Mow

Stock Details


Company's stock symbol is NASDAQ:CRBP

Investors List

dafna-capital-management_image

Dafna Capital Management

Dafna Capital Management investment in Post-IPO Equity - Corbus Pharmaceuticals

ghost-tree-capital-group_image

Ghost Tree Capital Group

Ghost Tree Capital Group investment in Post-IPO Equity - Corbus Pharmaceuticals

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Post-IPO Equity - Corbus Pharmaceuticals

the-cystic-fibrosis-foundation_image

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation investment in Grant - Corbus Pharmaceuticals

fort-point-angels_image

Fort Point Angels

Fort Point Angels investment in Venture Round - Corbus Pharmaceuticals

oleg-uritsky_image

Oleg Uritsky

Oleg Uritsky investment in Venture Round - Corbus Pharmaceuticals

sternaegis-ventures_image

SternAegis

SternAegis investment in Venture Round - Corbus Pharmaceuticals

boston-harbor-angels_image

Boston Harbor Angels

Boston Harbor Angels investment in Angel Round - Corbus Pharmaceuticals

Official Site Inspections

http://www.corbuspharma.com Semrush global rank: 9.44 M Semrush visits lastest month: 157

  • Host name: ec2-54-208-101-55.compute-1.amazonaws.com
  • IP address: 54.208.101.55
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Corbus Pharmaceuticals" on Search Engine